Transforming growth factor-β-induced mitogenesis of human bone cancer cells

Biochemical and Biophysical Research Communications

Volumn 161, Issue 2, 1989, Pages 672-676

  Datta, Harish K ^a   Zaidi, Mone ^a   Champaneri, Jayant B ^a   MacIntyre, Iain ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

INDOMETACIN; RADIOISOTOPE; TRANSFORMING GROWTH FACTOR BETA;

CANCER CELL; CELL DENSITY; CELL GROWTH; GROWTH INHIBITION; HUMAN; HUMAN CELL; MITOGENESIS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

BONE NEOPLASMS; CELL DIVISION; DNA, NEOPLASM; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMAN; IN VITRO; OSTEOBLASTS; OSTEOSARCOMA; SUPPORT, NON-U.S. GOV'T; TRANSFORMING GROWTH FACTORS; TUMOR CELLS, CULTURED;

EID: 0024373505     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/0006-291X(89)92651-X     Document Type: Article

References (15)

1. Transforming growth factors. Isolation, characterization, and interaction with cellular receptors.
2. The TGF-β family of growth and differentiation factors
3. Mesoderm induction in amphibians: the role of TGF-beta 2-like factors.
4. Transforming growth factor beta is a bifunctional regulator of replication and collagen synthesis in osteoblast-enriched cell cultures from fetal rat bone.
5. Alpha and beta human transforming growth factors stimulate prostaglandin production and bone resorption in cultured mouse calvaria.